BCN­In­ter­me­di­a­te­ofCe­f­capene CAS 153012-37-4

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions andamp ; Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

153012-37-4

Name

BCN­In­ter­me­di­a­te­ofCe­f­capene

Syn­onyms

(6S,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2E)-2-(2-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsäure –N-iso­propyl-2-pro panamin (1:1) [Ger­man] [ACD/IUPAC Name] (6S,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2E)-2-(2-{2-[(2-methyl-2-propanyl)oxy]-2-oxoethyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid – N-iso­propyl- 2-propanamine (1:1) [ACD/IUPAC Name] 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[(2E)-2-[2-[2-(1,1-dimethylethoxy)-2-oxoethyl]-4-thiazolyl]-1-oxo-2-penten-1-yl]amino]-8-oxo-, (6S,7R)-, com­pd. with N-(1-methylethyl)-2-propanamine (1:1) [ACD/​Index Name] Acide (6S,7R)-3-[(carbamoyloxy)méthyl]-7-{[(2E)-2-(2-{2-[(2-méthyl-2-propanyl)oxy]-2-oxoéthyl}-1,3-thiazol-4-yl)-2-pentenoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ène-2-carboxylique – N-iso­prop yl-2-propanamine (1:1) [French] [ACD/IUPAC Name] 153012-37-4 [RN] Boc-Cef­capene.DIPA

Mol­e­c­u­lar Structure

SMILES

CC/C=C(\c1csc(n1)CC(=O)OC(C)(C)C)/C(=O)N[C@H]2[C@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O.CC(C)NC(C)C

Std­InChI

InChI=1S/C23H28N4O8S2.C6H15N/c1-5-6-12(13-10-36-14(25-13)7-15(28)35-23(2,3)4)18(29)26-16-19(30)27-17(21(31)32)11(8-34-22(24)33)9-37-20(16)27;1-5(2)7-6(3)4/h6,10,16,20H,5,7-9H2,1-4H3,(H2,24,33)(H,26,29)(H,31,32);5-7H,1-4H3/b12-6+;/t16-,20+;/m1./s1

Std­InChIKey

IAVQLVKSVQCUFH-DUVQPXS­R­SA-N

Mol­e­c­u­lar Formula

C29H43N5O8S2

Prop­er­ties

Appear­ance

Yel­low­ish crys­talline pow­der

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our BCN­In­ter­me­di­a­te­ofCe­f­capene CAS 153012-37-4

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC,IR

Puri­ty

97% min

Loss on Drying

3.5% max

Absorbance(400nm, 1% MeOH)

0.2% max

Water(KF)

1.5% max

Stor­age

Under room tem­per­a­ture and away from light

Appli­ca­tion

Used as the phar­ma­ceu­ti­cal Inter­me­di­ates

Links

This prod­uct is devel­oped by our RD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​cam​ing​.com/​b​c​n​i​n​t​e​r​m​e​d​i​a​t​e​o​f​c​e​f​c​a​p​e​n​e​-​c​a​s​-​1​5​3​0​1​2​-​3​7​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).